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Abstract 
 
 
 
Clustered regularly interspaced short palindromic repeats, or CRISPR, is a relatively new 
gene-editing technology that has the possibility of making a large impact to plant breeding. This 
paper will introduce how the CRIPSR system works, and will give a few examples of how the 
technology is currently being used in plant breeding. It will also look at the current regulatory 
systems and how that might affect the use of CRISPR technology in our food system. Finally, 
this paper will look at consumer acceptance of GMOs; how GMOs have been perceived in the 
past, and what learnings we can take as we advance CRISPR into new plant biotechnologies.  
 
Introduction 
 
 
Plant breeding has a long history, going back to the beginning of human civilization, 
where seeds were saved from plants that had the best traits or best yield (Brown, 2015). Plant 
breeding has been used for years to produce varieties that perform better than the previous 
generations. Over time, plant breeding has become more advanced as scientific technologies 
have been improved; from the random saving of seeds for the next generation to using 
technologies such as CRISPR to make precise edits in the plant genome.  
Advancements have been made in traits such as yield, drought resistance, and pest 
resistance. These advancements benefit society, whether it be by providing more food because 
yields have increased, or being able to provide more affordable food because famers are able to 
use less pesticides or water to grow their crops, and therefore are able to pass that savings onto 
the consumer.  
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New genome editing technologies are being used in many different fields, including 
medicine, plant breeding, and animal breeding. In this paper, the focus will be on the role of 
CRISPR-Cas technology in plant breeding. CRISPR-Cas technology may greatly benefit plant 
breeding and completely change the way plant breeding is currently being conducted. With 
CRISPR-Cas technology, changes to the plant genome can be done in a nucleotide-specific 
manner; either modifying, inserting or knocking out a gene (Bortesi, 2015). This is an exciting 
technology for the plant breeding field, and has the potential to bring new products to the market 
in a much quicker and cheaper way, possibly by avoiding the lengthy gene deregulation process 
required for genetically modified crops accomplished through plant transformation.  
 
CRISPR-Cas 9 Overview 
 
Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences, 
approximately 25-50 nucleotides long, separated by short sequences called spacers (Marraffini, 
2010), that are being used as part of a relatively new gene-editing technology. CRISPR systems 
were first detected in Escherichia coli in 1987, but the actual function of CRISPRs were not 
discovered until the mid-2000s (Ishino, 2018).  
In 1993, CRISPRs were observed in archaea, and then in genomes of multiple bacteria 
and archaea. In the early 2000s, it was discovered that the spacer regions of CRISPRs were 
similar in various organisms. Through comparison of CRISPR regions from various organisms, 
four common characteristics were discovered. First, they are in intergenic regions. Second, they 
contain multiple short repeats with little variation. Third, the repeats are interspersed with 
nonconserved sequences. Fourth, a common leader sequence is located on one side of the repeat 
cluster (Ishino, 2018). 
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In the mid-2000s, three independent studies found that the spacer regions were 
homologous to sequences of bacteriophages, prophages, and plasmids, and that phages and 
plasmids failed to infect those strains that had the homologous spacer sequences. They proposed 
that CRISPR sequences provide a defense system (Ishino, 2018).  
CRISPRs were first characterized as an adaptive immune system by Barrangou et al. 
(2007). The function of CRISPR as an adaptive immune system was first established in 
Streptococcus thermophilus. Insertion of the phage sequence into the CRISPR region of S. 
thermophilus resulted in a phage-resistant strain. When a bacterium survives a virus attack, the 
cell integrates part of the viral DNA into its own genome, which was coined as the CRISPR 
sequence (Bartkowski, 2018), providing a “genetic memory” of the infectious virus (Marraffini, 
2010), an example of which is presented in the top portion of Figure 1. The next time the 
bacterium is attacked by the virus, an RNA copy of the viral DNA is made which serves as a 
targeting mechanism. The RNA copy binds to an enzyme, called Cas9, and the system then cuts 
the viral DNA at a specific sequence, which was integrated into the bacterial genome during 
prior infection. This eliminates any further multiplication of the virus (Bartkowski, 2018). The 
bottom portion of Figure 1 illustrates this mechanism. CRISPRs can be reprogrammed so that the 
CRISPR-Cas system can recognize DNA molecules that haven’t been encountered before 
(Marraffini, 2010). It was discovered that the CRISPR-Cas RNA (crRNA) complex can cleave 
target DNA in vitro (Ishino, 2018). 
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Figure 1. The process of CRISPR as an acquired immune system. The top image shows the 
invading DNA that is recognized by the Cas protein, and then incorporated into the spacer 
regions. The bottom image shows pre-crRNA generated through transcription and then processed 
into crRNA. Foreign DNA is then captured and cleaved. (Source: Ishino, 2018).  
 
 
Comparative analyses of CRISPR regions amongst multiple organisms revealed four 
conserved genes are regularly present next to the CRISPR regions. These are called CRISPR-
associated genes (Cas genes) (Ishino, 2018). These Cas genes fall into two classes of CRISPR-
Cas systems, Class 1 and Class 2. Class 1 systems work with multi-subunit effector complexes 
that are made up of 4-7 Cas proteins, which are common in bacteria and archaea, and represent 
about 90% of all identified CRISPR-Cas loci. Class 2 systems use a single multidomain effector 
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protein, are found only in bacteria, and represent about 10% of all identified CRISPR-Cas loci. 
Within Class 1 systems, there are three types: type I, type III, and type IV. Within Class 2 
systems, there are three types: type II, type V, and type VI. The type II system includes the Cas9 
protein (Ishino, 2018).  
 
CRISPR-Cas technology for genome editing is based on this naturally occurring 
immunity mechanism in bacteria (Bartkowski, 2018). The S. thermophilus CRISPR-Cas system 
has been applied to gene editing in human nerve and mouse kidney cells (Ishino, 2018). The 
CRISPR-Cas 9 system, the most common CRISPR-Cas mechanism, is used in gene editing. It is 
adapted from Streptococcus pyogenes (Ferreira et al., 2018). Today, the type II signature protein 
Cas9 is the one that is the most popular and the most used effector protein (Brandt, 2019). Cas9 
can be guided to a specific DNA target sequence adjacent to a protospacer-adjacent motif 
(PAM), a short DNA sequence of usually 2-6 base pairs located just after the DNA region that is 
being targeted by the CRISPR system (Belhaj, 2013).  
Two non-coding RNAs guide the CRISPR-Cas9 complex: CRISPR RNA (crRNA) and 
trans-activating crRNA (tracrRNA). In 2012, the synthetic single guide RNA (sgRNA) was 
created by fusing crRNA with tracrRNA, which functions similar to the crRNA/tracrRNA 
complex. Because of this advancement, the CRISPR-Cas9 system was brought down to two 
components — Cas9 and sgRNA. The sgRNA guide sequence is located at the 5’ end, and 
specifies the DNA target (Belhaj, 2013). When it reaches the target, the Cas9 recognizes the 
PAM sequence (5’-NGG-3’) and cleaves the DNA sequence at three nucleotides upstream of the 
PAM, creating a double strand break in the DNA molecule (Ferreira et al., 2018). The N in the 
NGG sequence can be any nucleotide. Based on these observations, RNA-guided engineered 
nucleases (RGENs) have been invented to modify target sequence in a sequence-specific manner 
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for precise genetic modifications. RGENs are comprised of the Cas9 nuclease and an engineered 
single guide RNA (sgRNA) which has 20 nucleotides at the 5’ end that directs the Cas9 nuclease 
to the target site (Khatodia, 2016). 
Other types of Cas nucleases can recognize different PAM sequences providing 
researchers the flexibility of using a different Cas protein. However, Cas9 is still the most 
commonly used endonuclease (Synthego, 2019). The ability to reprogram CRISPR-Cas 
endonuclease specificity using sgRNAs has been of great advantage for genome editing 
applications. By modifying the guide sequence, sgRNAs with different target specificities can be 
created (Belhaj, 2013).  
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Figure 2. A schematic representation of the CRISPR-Cas9 system. Cas9 is guided to the target 
site by the sgRNA. The target site is located at 5’ of the PAM sequence. Once at the target site, 
there is a double stranded break in the DNA and the DNA is then repaired by either non-
homologous end joining or homologous recombination process (Khatodia, 2016).   
 
 
Figure 2 shows a general schematic of the CRISPR-Cas9 system. The sgRNA guides the 
Cas9 to the target site, eventually leading to a double-stranded break. Double-stranded breaks 
(DSBs) created by CRIPSR-Cas can be repaired by either homologous directed repair (HDR) or 
non-homologous end-joining (NHEJ) (Chen, 2019). HDR occurs when there is a corresponding 
homologous template (Su, 2016). The repair template for HDR can be a sister chromatid, an 
exogenous DNA, or a single-strand DNA containing the desired sequence that will be 
incorporated into the break site (Chang, 2017). HDR can introduce precise point mutations like 
nucleotide substitutions or HDR can insert desired sequences through recombination of the target 
locus with exogenously supplied DNA templates (Khatodia, 2016).  
Non-homologous end-joining (NHEJ) does not need a homologous template (Su, et al., 
2016). DNA double-stranded breaks are largely repaired by non-homologous end-joining process 
(Chang, et al., 2017). Usually, NHEJ causes random insertions or deletions, which can result in 
frameshift mutations in a coding region of a gene. The frameshift mutations can create a gene 
knockout (Bortesi, 2015). While NHEJ is very efficient and useful for large scale knockouts, it is 
not a precise as HDR-mediated genome editing.   
CRISPR-Cas technology is precise; changes can be as simple as one base pair being 
removed or replaced. Therefore, the genetic changes in the descendants are indistinguishable 
from point mutations that could occur naturally (Gross, 2016).  
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Off-target activity is one of the concerns of using CRISPR-Cas. Off target activity is 
when a non-targeted sequence is recognized, instead of or in addition to the target sequence. 
Mismatches between the DNA target and the guide sgRNA sequence within the last 8-10 base 
pairs of the target sequence are not tolerated by Cas 9; whereas mismatches towards the 5’ end of 
the target sequence are better tolerated by the enzyme in performing its endonuclease cleavage 
function (Belhaj, 2013). The whole genome sequencing in plants has shown that negligible 
mutations occur at off-target sites. In plants, off-target mutations induced by CRISPR-Cas9 is 
not of a major concern because background mutations can be purged via segregation in the 
selfing-generations.  
One way to reduce off target activity could be to lower the level of Cas9 and/or sgRNA 
expression. Use of truncated sgRNAs has also shown to alleviate the problem. Shorter sgRNAs 
are more sensitive to nucleotide mismatches and could reduce off-target mutations (Belhaj, 
2015). The best way to reduce off target activity is to select the right target sites, based on 
sequence information. The best target sites would be the ones that have minimum predicted off 
targets (Hahn, 2019). 
Before 2013, the two most prominent genome editing tools for site-specific double strand 
DNA breaks were zinc finger nucleases (ZFNs) and transcription activator-like effector 
nucleases (TALENS). Both are artificial fusion proteins, created by fusing an engineered DNA-
binding domain to the nonspecific nuclease domain of a restriction enzyme (Bortesi, 2015). 
These tools were not widely adopted due to complicated design and laborious and time-
consuming assembly of specific DNA binding proteins for a target gene sequence. In addition to 
simplicity in design, CRISPR-Cas, can be multiplexed to target several genes in parallel, and is 
now accessible to many plant science laboratories (Rogowsky, 2017). 
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Impact of CRISPR Cas Technology on Plant Breeding  
 
 
CRISPR-Cas can be a useful tool in plant breeding. However, to apply CRISPR-Cas 
technology to improve a trait one must have the knowledge of the genes that govern the trait 
(Rogowsky, 2017). Use of CRISPR-Cas in plant breeding looks to be more promising than in 
animal breeding. In plant breeding, small edits in the genomes can lead to large improvements in 
efficiency because of the specific targeting mechanism of CRISPR-Cas. CRISPR-Cas in plant 
breeding can also affect disease resistance, and nutritional value (Gross, 2016). The lengthy 
recurrent backcrossing process can now be replaced with the rapid CRISPR-Cas technology 
(Rogowsky, 2017). Backcrossing is time consuming and can take easily seven years for at least 
four rounds of backcrossing to transfer the desired trait from the donor parent to the recurrent 
parent. More importantly, the developed CRISPR-Cas-mediated products are free from any 
possible linkage drag. Linkages of undesirable genes with the trait-gene of interest many times 
compromise the yield potential of cultivars developed through backcrossing. With CRISPR-Cas, 
the traits can be immediately incorporated requiring significantly less time than traditional 
backcross breeding and products are free from any linkage drag.  
The first food edited with CRISPR-Cas and cleared by the United States Department of 
Agriculture (USDA) is the common white button mushroom (Agaricus bisporus). The 
technology was used to reduce browning of the mushroom. CRISPR-Cas allowed knocking out 
just one of six genes encoding polyphenol oxidases (Gross, 2016). By deleting a few base pairs 
of one of the six polyphenol oxidase genes, the enzyme activity was reduced by 30%. As a result, 
oxidation of phenols was reduced significantly and so was the browning (Waltz, 2016). 
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Another product of CRISPR-Cas technology is waxy corn. Waxy corn, genetically 
modified using CRISPR-Cas 9 by Corteva, contains 100% amylopectin, used in processed foods, 
adhesives, and high gloss paper. Using the CRISPR-Cas9 gene-editing tool, the Corteva team 
knocked out the endogenous waxy gene Wx1, which encodes the endosperm's granule-bound 
starch synthase that synthesizes amylose from ADP-glucose pyrophosphorylase (Waltz, 2016).  
Some examples of traits that have been approached with CRISPR-Cas technology are 
listed below:  
• Resistance to powdery mildew in wheat (Wang et al., 2014) 
• Resistance to 3 potyviruses in cucumber (Chandrasekaran et al., 2016) 
• Resistance to Botrytis in grape (Wang et al., 2017) 
• Canker resistance in citrus (Peng et al., 2017) 
• Dwarfism in barley (Lawrenson et al., 2015) 
• Oil enriched in oleic acid in soybean (Haun et al., 2014) 
• Starch quality (Andersson et al., 2017), phosphate transport (Zhou et al., 2017), and auxin 
transport in potato (Wang et al., 2015) 
• Non-browning mushrooms (Gross, 2016) 
• Waxy corn (Waltz, 2016) 
 
 
 
Regulation of GMOs and CRISPR technology  
 
GMOs, genetically modified organisms, are defined as organisms (plants, animals, or 
microorganisms) in which the DNA has been altered in such a way that it would not occur 
naturally by mating and natural recombination. They can be developed by transferring selected 
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individual genes from one organism into another (WHO, 2014). Regulation of genetically 
modified crops is conducted by three agencies in the United States: the United States Department 
of Agriculture (USDA), the Environmental Protection Agency (EPA), and the Food and Drug 
Administration (FDA). 
 
Regulation of GMOs available in the Library of Congress website is presented below: 
“GMOs are regulated in the United States under the Coordinated Framework for  
Regulation of Biotechnology, published in 1986, pursuant to previously existing statutory  
authority regulating conventional products, with a focus on the nature of the products  
rather than the process in which they are produced.  
 
Plant GMOs are regulated by the US Department of Agriculture’s Animal and Plant  
Health Inspection Service under the Plant Protection Act.  GMOs in food, drugs, and  
biological products are regulated by the Food and Drug Administration under the  
Federal Food, Drug, and Cosmetic Act and the Public Health Service Act.  GMO,  
pesticides and microorganisms are regulated by the Environmental Protection Agency  
pursuant to the Federal Insecticide, Fungicide and Rodenticide Act and the Toxic  
Substances Control Act. The form of regulation varies depending on the type of GMO  
involved” (Acosta, 2014). 
 
Under the current regulations, it takes on average $136 million (Figure 3) and 13.1 years 
(Table 1) for a GMO to go from discovery to commercialization (McDougall, 2011). These 
charts do not include deregulation of stacked transgenes. It is expected that CRISPR-Cas edited 
genotypes are most unlikely to go through the same rigor of deregulation process as for the GM-
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cultivars. (USDA, 2018). An added advantage of CRISPR-Cas in plant breeding is the feasibility 
of multiplex sgRNAs for editing two or more target genes (Belhaj, 2015). This can save time in 
creating the products for multiple traits as well as going through the regulation process.  
  
Figure 3. The overall cost of a new plant biotechnology trait, introduced between 2008 and 2012. 
This is based on data from six largest biotechnology crop developers of seed industries. The 
chart represents the cost of discovering a trait, development of a product for production, and 
regulatory testing for deregulation and registration (Source: McDougall, 2011).  
 
 
 
 
 
 
 
Table 1. The overall time taken from discovery to commercialization of a new plant 
biotechnology trait, introduced between 2008 and 2012. This is based on data from six largest 
biotechnology crop developers of seed industries. 
  
The table does not include time taken to obtain regulatory approval for traits governed by stacked 
transgenes, which are incorporated in a large portion of most crops today (Source: McDougall, 2011). 
 
Regulatory 
Testing and 
Registration
26%
Discovery
23%
Development
51%
COST OF A NEW PLANT BIOTECH TRAIT (IN 
MILLIONS)
Canola Corn Cotton Soybean All crops
Number of Years from Discovery to Commercialization 11.7 12 12.7 16.3 13.1
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Regulations of GMO around the world can be either process-based or product-based. 
Process-based GMOs are subjected to regulatory reviews based on the scientific assessment of 
the processes used to create the GMOs and the risks to human health and the environment. 
Product-based GMO regulations is based on the final product rather than on the processes used 
to generate the GMOs (Araki, 2015). European Union countries regulate GMO based on the 
process (Zetterberg, 2017); whereas, in the U.S. GMO is regulated based on the products 
(Acosta, 2014).  
The first CRISPR-Cas edited crops could be cultivated and sold without any oversight or 
deregulation process under its biotechnology regulations division of the United States 
Department of Agriculture (USDA) because the products are not different from the ones 
developed through traditional plant breeding. In the USDA press release of March 28, 2018, the 
United States Secretary of Agriculture Sonny Perdue stated that USDA does not regulate, nor do 
they have plans to regulate plants that could otherwise have been developed through traditional 
plant breeding techniques, as long as they are not plant pests or were developed using plant pests 
(USDA, 2018). This is an important development for the new CRISPR-Cas technologies because 
it will facilitate rapid release of novel crop cultivars without the hassle of expensive and time-
consuming regulatory processes applied to GMOs developed through plant transformation. 
The first example of a CRISPR-Cas edited product is the mushroom, Agaricus bisporus. 
The USDA concluded that the CRISPR-Cas edited mushroom required no state regulation in the 
U.S. because no foreign DNA has been introduced into the organism (Gross, 2016). As stated 
earlier, the non-browning type mushroom was created by knocking out a gene encoding 
polyphenol oxidase that is responsible for browning. There was no trace of any foreign DNA in 
the CRISPR-Cas edited mushroom; therefore, the modified mushroom was considered a GM 
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product indistinguishable from those obtained through conventional mutation breeding or use of 
an allele generated through spontaneous mutation (Bartkowski, 2018).  
In the past, when the U.S. government was developing its regulation for GMOs, viral or 
bacterial genes were used in developing genetically modified plants (Waltz, 2016). Those GMOs 
can be distinguished from products that occur naturally, which is why GMOs are regulated under 
the current U.S. regulation process. 
CRISPR-Cas edited waxy corn is expected to be marketed in 2020. Neil Gutterson, the 
Senior Vice President and Chief Technology Officer of Corteva Agriscience, reported that his 
team started to work on developing the new waxy corn trait in early 2015. “One observation or 
lesson we have with our first product is that the reduced time to market is significant,” he added. 
It takes less than five years for a CRISPR-Cas edited corn, as opposed to eight years for a hybrid 
corn, to reach farmers. The USDA treated the CRISPR-Cas edited waxy corn the same way as it 
treats a similar product developed through conventional plant breeding approaches because it 
does not add any foreign genes (Bomgardner, 2017). If the United States continues to allow 
CRISPR-Cas edited crops to be cultivated and sold without any USDA oversight, this would 
reduce the cost of development of a product by millions of dollars (Waltz, 2016). The ease of use 
of the technology and no need of any deregulatory process are expected to facilitate development 
of CRISPR-Cas mediated genome editing by even smaller companies and developing countries, 
which is not the case for the current transgenic products, popularly known as GMOs (Gross, 
2016).  
 
 
GMOs and Consumer Acceptance 
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Google Trends shows that google searches for the term “GMO” from 2004 peaked in 
May of 2013 [Reference or Figure]. Since their introduction to the commercial market in the 
1990s, genetically modified (GM) foods have received quite a bit of opposition from the public 
because of concerns about possible environmental and health risks. The majority of scientists, 
however, are favorable towards GM foods (McPhetres, 2019). In 2016, the National Academy of 
Sciences formed a Committee on Genetically Engineered Crops. They studied over 900 
publications, attended meetings and webinars, and gathered public comments. Their research 
found no convincing evidence for negative health or environmental effects of GM foods (Gould, 
2016).  
While the research shows no convincing evidence, the general public’s understanding of 
GMOs or the science behind GMO production is very low. Most consumers receive their 
information on GMO food products from the media, the internet or other news sources, which 
are unlikely reliable than scientific publications (Wunderlich, 2015). In a survey taken by 
Oklahoma State University in 2015, 82% of those surveyed support mandatory labels on GMOs, 
and 80% said they support mandatory labels on foods “containing DNA” (Lusk, 2015). The 
majority of items bought in a grocery store “contain DNA”; the majority of the public seems to 
be unaware of this scientific fact.  
 McPhetres et al. (2019) reported that a lack of science knowledge for GM technology is a 
strong predictor of GM food skepticism. McPhetres et al. (2019) also showed that if people 
learned about the science behind GM technology, they tend to develop positive attitudes towards 
GM foods, a greater willingness to accept GM foods, and lowered their perceptions that GM 
foods bear health risk (McPhetres, 2019).  
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Discussion 
 
CRIPSR-Cas is a relatively new technology that allows precise editing of DNA sequences. 
This paper focuses on the invention of CRISPR and development of CRISPR-Cas technology 
that has been used in designing crop cultivars. It discusses no requirement of a regulatory process 
for the products generated by the CRISPR-Cas technology in the United States. CRISPR-Cas is 
an exciting new tool for plant breeders because it allows the plant breeding process to be precise 
and requires much less time as compared to that in the traditional plant breeding in generating a 
new trait. Whereas in the past, a plant breeder may take over seven years to add a new trait 
through back crossing, CRISPR-Cas can create new alleles of a gene or knockout a gene in a 
matter of 2-3 years to genetically improve a trait. Such products are also completely free from 
any possible linkage-drags of undesirable genes located next to the target gene, which is usually 
happened during cultivar development through backcrossing of the desirable target allele into an 
established cultivar. A possible pitfall of the technology are off-target mutations, which can be 
purged from the final product through selfing and segregation.  
The regulation of GMO products depends on the countries’ laws and how the product is 
viewed; if it regulated based on the nature of the product or the process used to create the 
product. In the United States, it is currently being regulated based on the nature of the product. 
The products developed through CRISPR-Cas technology are indistinguishable from products 
developed through induced or spontaneous mutations, and is distinct from GMOs generated 
through introduction of foreign genes through plant transformation. Therefore, the crop cultivars 
developed using CRISPR-Cas technology are considered no different from the products 
developed through traditional plant breeding approaches and do not require regulation.  
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While the lack of regulation of products developed by CRISPR-Cas technology is a large 
factor for successful application of the technology in crop improvement, it is equally important 
to have consumer acceptance of the CRISPR-Cas products. Without consumer acceptance, 
CRISPR-Cas edited products face the same challenges as GM products have.  With GM foods, 
most consumers are uneducated on the science, and there is a lot of skepticism regarding 
genetically engineered foods. In the beginning, when transgenic technology was used, there was 
a lack of efforts in providing awareness of the technologies among the consumers. Scientists and 
farmers thought consumers would accept GM products because they provide so many benefits. 
Not knowing enough about the technology and because of misconceptions about GMO 
propagated in the media, the consumers developed negative attitude towards GM products. As a 
result, consumers buy certified non-GM products or organic products, avoiding GMOs. They are 
concerned about their health and well-being; they negatively view GM foods. Only 52% of 
consumers aware how GMOs are created or developed (Crawford, 2015). In a 2015 Pew 
Research Center study, 57% of U.S. consumers considered eating GM foods “generally unsafe.” 
Eleven percent of scientists associated with the American Association for the Advancement of 
Science consider the same (Hofbauer, 2016). Table 2 presents the consumer knowledge of 
GMOs collected through four surveys.  
 
Table 2. Consumer surveys on knowledge of GMOs.  
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       Source: U.S. consumers (Wunderlich, 2015). 
 
 It is also hard for consumers to have the correct information when there are misleading 
labels. For example, the “Non-GMO Project” label is also used on foods of many crops for 
which no known GMOs are available. As for example, a non-GMO-labelled cereal made from 
100% wheat although there is no GM wheat grown anywhere commercially in the world. 
Similarly, “Non-GMO Project” certified avocado oil with no GM avocado grown anywhere 
(Wager, 2016). These misleading labels add to the confusion of GMOs for the general consumer. 
Most consumers will take the label as is, and assume there is a GMO version of the product. 
Even salt is sometimes labelled as non-GMO. 
Scientists, by educating on science of GMO, can change public’ opinions. Take the 
example of Bill Nye, GMO opponent. For over 10 years, he had strong concerns over GM crops. 
In 2015, he publicly announced that he changed his mind on GMO after visiting Monsanto 
scientists. Opponents of GMO denounced him and said that propaganda scientists brainwashed 
him into changing his position. But, Bill Nye wrote in his book “Unstoppable: Harnessing 
Science to Change the World” that he accepted the evidence and became aware of the 
Sample Size Main findings
48% know that GMOs were available in supermarkets
31% believe that they have most likely consumed a GMO product
Limited self-rated knowledge about GMOs
48% know very little about GMOs
16% know nothing at all about GMOs
30% know a fair amount about GMOs
5% know a great deal about GMOs
43% know GMO products are sold in supermarkets
26% believe that they have most likely consumed a GMO product
54% know very little or nothig about GMOs
25% have never heard of GMOs
59% knw that GMO soybeans are sold in US supermarkets
56% mistakenly believe that GMO tomatoes are sold
55% mistakenly believe that GMO wheat is sold
50% mistakenly believe that GMO chicken is sold
n=1201
n=600
n=1148
n=491
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unscientific nature of the anti-GMO movement (Pomeroy, 2016). It is clear that it will be an 
uphill battle to gain wide acceptance of GMOs, but if more people can be educated on the 
science, the benefits, and the safety of the products, there could be a wider acceptance of the 
technology.  
I think it will be best to educate the consumer on CRISPR-Cas technology even before 
the products are made available to the market to avoid any negative impression of the safe GM 
products using this technology.  Otherwise as in GMO, generated through transgenic 
technologies, it will be hard to gain the public trust on this new CRISPR-Cas edited GM 
products. Transparency and education are the ways to avoid any misperception of CRISPR-Cas 
technology and gain trust of consumers for making this novel high precision genome-editing 
technology a successful one, urgently needed for a second generation of green revolution! 
 
 
Conclusions 
 
CRISPR-Cas technology has allowed scientists to make sequence-specific changes to a 
plant genome. These changes are indistinguishable from changes that could occur naturally 
through spontaneous or induced mutation. Because of this principle, current regulations for 
CRISPR-Cas products in the United States are different from those for GMO. The USDA does 
not have any plans to regulate CRISPR-Cas edited crops, which means it will be affordable to 
develop CRISPR-Cas products by both small and large seed companies; and we expect to 
witness a wider participation of scientists for improving crops. If the USDA continues not to 
regulate CRISPR-Cas edited crops in the United States, the major deciding factor for using 
CRISPR-Cas technology will be the acceptance of CRISPR-Cas edited foods by consumers. 
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Educating the consumers for science of the new technology will be the key in convincing the 
consumers that the developed new cultivars through this technology is not different from the 
ones developed through traditional mutation breeding approach. Scientists have learned a great 
lesson while working on transgenic technology on how important it is to educate the public on 
the science of plant transformation and transgenic plants to gain their trust. This experience is 
expected to make the CRISPR scientists more proactive in educating the public regarding the 
science behind this genome editing technology. 
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